Organon and Sempre Health announce collaboration on new service to help eligible patients save money and stay on their medication as prescribed

Organon (NYSE:OGN) and Sempre Health today announced a strategic partnership designed to motivate eligible patients to refill their prescriptions on time and improve adherence through an innovative pricing program that offers personalized support.

Early data are promising for autoimmune disease drug from Roivant Sciences’s Immunovant

Results released Tuesday from an early study of an autoimmune disease drug from Roivant Sciences’s Immunovant showed the treatment could reduce the levels of a

September 26, 2023

RAP-C: Stalling California Psychedelic Studies

The TDR Three Key Takeaways: 1. RAP-C (Research Advisory Panel of California) is causing significant delays in psychedelic and addiction treatment research due to a

January 25, 2024

Opinion | Perception Is Reality: NIH’s Role on Drug Pricing and Data Transparency

Jeremy Faust is editor-in-chief of , an emergency medicine physician at Brigham and Women’s Hospital in Boston, and a public health researcher. He is author

April 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.